PT Pyridam Farma Tbk (PYFA) Stock Price & Analysis
PYFA Stock Chart & Stats
- Day’s Range
- IDR 104.00 - IDR 134.00
- 52-Week Range
- IDR 104.00 - IDR 625.00
- Previous Close
- IDR 108.00
- Volume
- N/A
- Average Volume (3M)
- 16.77M
- Market Cap
- IDR 1.33T
- Enterprise Value
- IDR 7.92T
- Total Cash (Recent Filing)
- IDR 127.11B
- Total Debt (Recent Filing)
- IDR 5.39T
- Price to Earnings (P/E)
- ―
- Beta
- 1.95
- Next Earnings
- Apr 15, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- May 31, 2019
- Dividend Yield
- N/A
PYFA FAQ
What was PT Pyridam Farma Tbk’s price range in the past 12 months?
What is PT Pyridam Farma Tbk’s market cap?
When is PT Pyridam Farma Tbk’s upcoming earnings report date?
How were PT Pyridam Farma Tbk’s earnings last quarter?
Is PT Pyridam Farma Tbk overvalued?
Does PT Pyridam Farma Tbk pay dividends?
What is PT Pyridam Farma Tbk’s EPS estimate?
How many shares outstanding does PT Pyridam Farma Tbk have?
What happened to PT Pyridam Farma Tbk’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PT Pyridam Farma Tbk?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PT Pyridam Farma Tbk
PT Pyridam Farma Tbk, an Indonesian-based enterprise, specializes in the development, production, and distribution of a broad spectrum of health-related products. Its offerings encompass pharmaceuticals, antibiotics, essential vitamins, dietary supplements, and traditional herbal remedies. The company's operations are divided into two main segments: Pharmaceutical Products and Contract Manufacturing Services, and Medical Device Products. Within its medical device division, the firm provides a variety of instruments and consumables. These include clinical waste management items, collection swabs and tubes, innerbox DCA, KF94 masks, parafilm, PCR extraction kits and their accompanying machinery, specimen bags, sterile containers, and tube stoppers. Furthermore, PT Pyridam Farma markets a diverse collection of skincare products, such as Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel. Its pharmaceutical portfolio addresses numerous therapeutic areas, including digestive and metabolic health, blood and blood-forming organ conditions, cardiovascular disorders, dermatological ailments, genitourinary system and sex hormone regulation, systemic corticosteroids, systemic antibacterial treatments, sensory organ issues, as well as musculoskeletal, nervous, and respiratory system conditions. Beyond medicinal lines, the company also develops and sells dietary supplements and preventive consumer health items, notably energy drinks and various healthy ready-to-consume beverages. A key area of its strategic focus involves conducting extensive research and development in biotechnology, life sciences, and medical science. Established in 1976, PT Pyridam Farma Tbk is headquartered in Jakarta, Indonesia.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yan Gwan Lee
- Employees
- 2,341
- Website
- www.pyfa.co.id
- Address
- Sinar Mas Land Plaza Sudirman, Jakarta, JK, 12920, ID
PT Pyridam Farma Tbk (PYFA) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 1 | 11 |

